Search - tctmd.com

Displaying 181 - 200 of 648

Sort: Relevancy | Date

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Features

Bullying in Cardiology: Has More Diversity Led to Backlash?

Caitlin E. Cox

December 14, 2022

News Daily News

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Michael O'Riordan

December 13, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

Michael O'Riordan

November 25, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

L.A. McKeown

November 11, 2022

News Conference News AHA 2022

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Michael O'Riordan

November 10, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News AHA 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Caitlin E. Cox

November 08, 2022

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

Advertisement

Top General Cardiology and Prevention News of 2022

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Bullying in Cardiology: Has More Diversity Led to Backlash?

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

TCTMD’s Top 10 Most Popular Stories for November 2022

Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Many STEMI Patients Not Treated Within National Time Goals

Sizeable Minority of Pregnant Women Have CVD, US Data Show

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

China Rural Intervention Still Reaping BP Control Wins at 3 Years

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content